Proteostasis

This page shows the latest Proteostasis news and features for those working in and with pharma, biotech and healthcare.

AbbVie and C2N take tau antibody into clinic

Meanwhile, Biogen licensed rights to a tau-targeting compound in development at Eisai for Alzheimer's in March, while Astellas signed a $1.2bn agreement with Proteostasis Therapeutics last November that

Latest news

Astellas earmarks up to $1.2bn for protein folding research

Astellas has teamed up with US company Proteostasis Therapeutics to investigate new ways of treating diseases caused by protein defects, an emerging field of pharmaceutical research. ... Astellas will work with Proteostasis initially on one undisclosed
Eisai forms neurology partnership with UCL

The two organisations also announced in May, 2011, they would be stepping up their efforts into neurodegenerative disease, including biomarker research into neuroinflammation, neurovascular/mitochondria and proteostasis.
Eastern Europe targeted

Licence. 83. Proteostasis/Elan. Discovery of disease-modifying small molecules for the treatment of neurodegenerative disorders.
Eisai/ UCL partnership grows

The new phase will see the Eisai and UCL engage in joint research in neurodegenerative disease including biomarker research into neuroinflammation, neurovascular/mitochondria and proteostasis.
Elan and Proteostasis partnership

There will also be an opportunity for Proteostasis to receive an additional $30m in collaboration funding over the next five years. ... Elan will become a 24 per cent shareholder in Proteostasis and will have the right of first negotiation to license

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest Intelligence

Deal Watch table for November 2014

Company divestment. 1, 530. Proteostasis Therapeutics / Astellas. Therapeutics modulating Unfolded Protein Response - multiple programmes.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

Proteostasis Therapeutics strengthens leadership team

Proteostasis Therapeutics strengthens leadership team. James DeTore, Geoffrey Gilmartin and Marija Zecevic join. ... Cambridge, Massachusetts-based Proteostasis Therapeutics has bolstered its leadership team with three new appointments.

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Scientific Communications Director - Oncology – In House Pharma ...: Neg

Client Services Director – Healthcare Advertising - London: Neg

Senior Project Manager - Medical Writing: Great salary and bebefits

Multi-Channel Account Managers - Road / Homebased – Full or Part...: Competitive salary

Account Director, Medical Communications: C£50 – 65, 000 benefits and bonus

Home based, Chief Medical Writer, Medical Communications: Excellent package

Home based, Senior Medical Writer, Medical Communications: Excellent package

Business Unit Head, Medical Communications, London: Excellent package

Account Manager: £40, 000 - £45, 000 benefits

Home based, Editorial Team Leader, Medical Communications: Excellent package

Account Director, Consumer Healthcare PR, Global PR agency: £50, 000 – £58, 000

Senior Account Manager: Competitive salary commensurate with experience

Delivery Manager/ Head of Delivery – Executive Search: Neg

Client Services Director - Med Comms: Great salary and bebefits

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

Home based, Principal Medical Writer, Medical Communications: Excellent package

Editorial Director – Medical Education (MedComms): Neg

Strategic Planner, Healthcare Advertising: £47, 000 – £53, 000

Subscribe to our email news alerts

PMHub

Add my company

Bedrock Healthcare Communications

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...